Inventor
NJOROGE F GEORGE
US100 patents
⚠️ This page may combine multiple inventors who share the name “NJOROGE F GEORGE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
41 patentsUS5874442AFeb 23, 1999
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
SCHERING CORP129 citations99
US6911428B2Jun 28, 2005
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP124 citations98
US5661152AAug 26, 1997
Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP137 citations98
US6838475B2Jan 4, 2005
Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP121 citations97
US6800434B2Oct 5, 2004
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP89 citations97
US6387905B2May 14, 2002
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP59 citations96
US6228856B1May 8, 2001
Compounds useful for inhibition of farnesyl protein transferase
SCHERING CORP60 citations96
US5994364ANov 30, 1999
Tricyclic antitumor farnesyl protein transferase inhibitors
SCHERING CORP58 citations96
US5801175ASep 1, 1998
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP68 citations96
US5721236AFeb 24, 1998
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP72 citations96
US5719148AFeb 17, 1998
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP92 citations96
US5714609AFeb 3, 1998
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP60 citations96
US5700806ADec 23, 1997
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP50 citations96
US5696121ADec 9, 1997
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP50 citations96
US5672611ASep 30, 1997
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP62 citations96
US7205330B2Apr 17, 2007
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP54 citations95
US6914122B2Jul 5, 2005
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
SCHERING CORP89 citations95
US6846802B2Jan 25, 2005
Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
SCHERING CORP124 citations95
US7592316B2Sep 22, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP34 citations93
US7442695B2Oct 28, 2008
Depeptidized inhibitors of hepatitis C virus NS3 protease
SCHERING CORP22 citations93
US7399749B2Jul 15, 2008
Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP21 citations93
US7253160B2Aug 7, 2007
Depeptidized inhibitors of hepatitis C virus NS3 protease
SCHERING CORP39 citations93
US6576639B1Jun 10, 2003
Compounds for the inhibition of farnesyl protein transferase
SCHERING CORP23 citations93
US6214828B1Apr 10, 2001
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
SCHERING CORP22 citations93
US6071907AJun 6, 2000
Tricyclic compounds useful as FPT inhibitors
SCHERING CORP21 citations93
US5958940ASep 28, 1999
Tricyclic compounds useful as inhibitors of farnesyl-protein transferase
SCHERING CORP33 citations93
US5807852ASep 15, 1998
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP20 citations93
US7485625B2Feb 3, 2009
Inhibitors of hepatitis C virus NS3/NS4a serine protease
SCHERING CORP33 citations92
US7342041B2Mar 11, 2008
3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7192957B2Mar 20, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7186747B2Mar 6, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP47 citations92
US7173057B2Feb 6, 2007
Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
SCHERING CORP44 citations92
US6894072B2May 17, 2005
Compounds as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP59 citations92
US6365588B1Apr 2, 2002
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP22 citations92
US6242458B1Jun 5, 2001
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP25 citations92
US6214827B1Apr 10, 2001
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP34 citations92
US6075025AJun 13, 2000
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP34 citations92
US5861395AJan 19, 1999
Compounds useful for inhibition of farnesyl proteins transferase
SCHERING CORP22 citations92
US5807853ASep 15, 1998
Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases
SCHERING CORP18 citations92
US5728703AMar 17, 1998
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP34 citations92
US5712280AJan 27, 1998
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
SCHERING CORP35 citations92
DENDREON CORP
3 patentsUS7012066B2Mar 14, 2006
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP176 citations98
US7244721B2Jul 17, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP80 citations97
US7169760B2Jan 30, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP88 citations97
KWONG CECIL D
3 patentsUS8470834B2Jun 25, 2013
AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
KWONG CECIL D40 citations93
US8715638B2May 6, 2014
Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
KWONG CECIL D40 citations92
US8541434B2Sep 24, 2013
Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
KWONG CECIL D39 citations92
GIRIJAVALLABHAN VINAY
2 patentsUS9061041B2Jun 23, 2015
2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GIRIJAVALLABHAN VINAY49 citations93
US9156872B2Oct 13, 2015
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GIRIJAVALLABHAN VINAY45 citations92
ARASAPPAN ASHOK
1 patentShowing the top 50 of 100 patents by PatentIndex Score.